Free Trial

Hillsdale Investment Management Inc. Sells 188,556 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Viemed Healthcare logo with Medical background

Hillsdale Investment Management Inc. lessened its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 19.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 768,573 shares of the company's stock after selling 188,556 shares during the quarter. Hillsdale Investment Management Inc. owned about 2.01% of Viemed Healthcare worth $6,033,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Mackenzie Financial Corp bought a new position in Viemed Healthcare in the third quarter valued at about $89,000. Strs Ohio boosted its stake in shares of Viemed Healthcare by 25.5% in the 3rd quarter. Strs Ohio now owns 76,300 shares of the company's stock valued at $513,000 after purchasing an additional 15,500 shares during the last quarter. Panagora Asset Management Inc. grew its position in shares of Viemed Healthcare by 58.7% during the 3rd quarter. Panagora Asset Management Inc. now owns 82,768 shares of the company's stock worth $557,000 after buying an additional 30,626 shares during the period. Boston Partners raised its stake in shares of Viemed Healthcare by 31.3% during the third quarter. Boston Partners now owns 56,430 shares of the company's stock worth $380,000 after buying an additional 13,468 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System acquired a new position in Viemed Healthcare in the third quarter valued at approximately $67,000. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Stock Up 0.6 %

NASDAQ VMD traded up $0.04 during trading on Friday, hitting $7.11. The stock had a trading volume of 181,488 shares, compared to its average volume of 146,850. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.14 and a current ratio of 1.28. Viemed Healthcare, Inc. has a 12 month low of $5.90 and a 12 month high of $10.68. The company has a market capitalization of $276.01 million, a PE ratio of 27.35 and a beta of 1.53. The company's 50-day moving average price is $8.40 and its two-hundred day moving average price is $8.16.


Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, March 6th. The company reported $0.09 EPS for the quarter. The company had revenue of $50.74 million during the quarter. Viemed Healthcare had a net margin of 5.32% and a return on equity of 9.32%.

Analysts Set New Price Targets

Separately, Lake Street Capital upgraded Viemed Healthcare to a "strong-buy" rating in a report on Tuesday, May 7th.

View Our Latest Stock Report on Viemed Healthcare

Viemed Healthcare Profile

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Stories

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Viemed Healthcare right now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines